Whittier Trust’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$3K 1734
2021
Q4
$3K Hold
100
﹤0.01% 1475
2021
Q3
$5K Hold
100
﹤0.01% 1335
2021
Q2
$5K Hold
100
﹤0.01% 1360
2021
Q1
$5K Hold
100
﹤0.01% 1357
2020
Q4
$5K Hold
100
﹤0.01% 1243
2020
Q3
$4K Hold
100
﹤0.01% 1262
2020
Q2
$3K Sell
100
-100
-50% -$2.77K ﹤0.01% 1230
2020
Q1
$6K Buy
+200
New +$5.99K ﹤0.01% 1192

Other funds holding NEO

Whittier Trust's NEO Position: Q1 2022 in Review

Whittier Trust sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 100 shares — an estimated $3K sold.

Whittier Trust first reported a position in NEO in Q1 2020 and held it in 8 quarters. The position peaked at $6K in Q1 2020. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Whittier Trust reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Whittier Trust sold 100 NeoGenomics shares in Q1 2022, an estimated $3K.
  • Whittier Trust first reported a position in NeoGenomics in Q1 2020 and held it in 8 quarters.
  • Whittier Trust's NeoGenomics position peaked at $6K in Q1 2020.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Whittier Trust's 13F filing for Q1 2022, filed 29 Apr 2022.